万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://journals.sagepub.com/home/dvr
3、投稿网址：https://mc.manuscriptcentral.com/dvdres
4、官网邮箱：p.j.grant@leeds.ac.uk（主编）
V.L.Harper@leeds.ac.uk（助理编辑）
5、期刊刊期：双月刊，一年出版6期。
2021年7月30日星期五
投稿须知【官网信息】
Manuscript Submission Guidelines: Diabetes and Vascular Disease Research
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the journal’s submission site https://mc.manuscriptcentral.com/dvdres to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.
Only manuscripts of sufficient quality that meet the aims and scope of Diabetes and Vascular Disease Research will be reviewed. As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
Diabetes and Vascular Disease Research may accept submissions of papers that have been posted on pre-print servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the journal. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy.
If your paper is accepted, you must include a link on your preprint to the final version of your paper.
If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal
1. Open Access
Diabetes and Vascular Disease Research is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.
For general information on open access at SAGE please visit the Open Access page or view our Open Access FAQs.
2. Article Processing Charge
If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons license.
The article processing charge (APC) for this journal is currently 1500 USD.
3. What Do We Publish
3.1 Aims and Scope
Before submitting your manuscript to Diabetes and Vascular Disease Research, please ensure you have read the Aims & Scope.
3.2 Article Types
The journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports. The suggested word counts only refer to the body of the text and exclude references etc.
Summary of manuscript structure
Title page (title of article, author names - forename, initials, surname - author affiliations, author for correspondence - title, address, telephone and fax numbers, email). Sole author articles should be accompanied by a relatively recent photograph of the author (at least 55 mm x 70 mm in size and at a minimum resolution of 300 dpi).
Originals, Reviews, Achieving Best Practice, Current Topics: Abstract 200 words, max. Key Words 6 max.; Abbreviations and Acronyms box (do not write in full in text); Key Messages 5 max.; Subheaded text, to include an Introduction and Conclusion/Discussion; References (ideally max. 30); Vancouver - <4 authors cite all, >4 authors cite first 3 et al.; Ref title. Journal year,vol:pages. Provide web addresses and month accessed. Tables - ideally submitted in Word. Figures - ideally submitted in PowerPoint using journal colours (pinks/maroon/grey) which can be modified to journal pantones by Production. Font styles should be consistent across all submitted figures. All figures and tables require legends and keys/abbreviations as appropriate. Photographs/Images - original image saved as .tiff or .eps file (minimum resolution 300 dpi), see section 9.4.3 for more details.
Short Reports: These are important preliminary data that justify early publication or briefer studies that warrant a short communication. Normally these manuscripts would be 1,500 words with 10-12 references and one figure or table.
Editorials, Case studies: As above but omit Abstract, Key Words and Key Messages.
Manuscripts should be structured as listed below.
Original papers
Should include:
Title page.
Abstract (200 words): a short inclusive statement suitable for direct electronic abstracting identifying the purpose of the study, key methods, the main results and the main conclusion.
Key words: maximum of 6 key words for indexing.
Introduction: concise description of background, sufficient for the non-specialist to appreciate the context of the work. Clear statement of the purpose of the study.
Methods: a brief description of study design, procedures, analytical techniques and statistical evaluation.
Results: a clear account of the study findings using quantitative language where possible and cross-referenced to tables and figures (ideally in PowerPoint using journal colours).
Discussion: an interpretation of the study placed within the context of current knowledge leading to specific conclusions where possible.
Each of the above sections should use subheadings as appropriate
Acknowledgements.
References (ideally max. 30), figures and tables (see 9.4.3 for more details)
Reviews, Achieving Best Practice and Current Topics
Should include:
Title page as above. Abbreviations & Acronyms box as necessary.
Abstract (200 words): setting out the scope, key messages and conclusions of the review.
Body of text: liberally partitioned with headings and subheadings leading to a synopsis with conclusions at the end.
Reviews ~2,500 words; Ach Best Pract 1,000-2,000 words; Curr Top 500-1,500 words
Should include:
Key messages: in a separate box itemising 2-5 very short principal points.
Acknowledgements.
References (ideally max. 30), figures and tables (see 9.4.3 for more details).
Editorial
Should include:
Title page as above. Abbreviations & Acronyms box as necessary.
Body of text: 500-2,500 words, liberally partitioned with headings and subheadings leading to a synopsis with conclusions at the end.
References (ideally max. 30), figures and tables (see 9.4.3 for more details).
Case Study
Should include:
Title page as above. Abbreviations & Acronyms box if necessary - if abbreviations only used once, write in full in text.
Introduction/case history as appropriate (see published studies). 200-500 words. Succinct Conclusion/Discussion containing the key learning points provided by the case If you are considering a longer Case study please follow all guidance for an Achieving Best Practice article.
Photograph/Image (original image saved as .tiff or .eps file - minimum resolution of 300 dpi - for scanned photographs see 9.4.3).
References (ideally max. 5), photographs, figures and tables (see 9.4.3 for more details).
If you would like to discuss your paper prior to submission contact the Editor-in-Chief (p.j.grant@leeds.ac.uk) or Editor’s Assistant (V.L.Harper@leeds.ac.uk).
3.3 Writing Your Paper
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.
3.3.1 Making your article discoverable
For information and guidance on how to make your article more discoverable, visit our Gateway page on How to Help Readers Find Your Article Online
4. Editorial Policies
4.1 Peer Review Policy
The journal’s policy is to have manuscripts reviewed by two expert reviewers. Diabetes and Vascular Disease Research utilizes a single-blind peer review process in which the reviewer’s name and information is withheld from the author. All manuscripts are reviewed as rapidly as possible, while maintaining rigor. Manuscripts are initially assigned to either the Editor-in-Chief who will make a decision regarding whether the manuscript fits within the aims and scope of the journal and is of sufficient priority to warrant peer review. At this stage some manuscripts may be immediately rejected. Papers which pass this initial check will then be assigned to either the Editor-in-Chief or a Section Editor who will manage the assignment of peer reviewers; each manuscript is reviewed by at least two referees. The Section Editor will then make a recommendation to the Editor-in-Chief regarding publication, primarily based on the reviewers comments. The Editor-in-Chief will make his final decision based on both this recommendation and the comments of the reviewers.
As part of the submission process you will be asked to provide the names of peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:
The reviewer should have no prior knowledge of your submission
The reviewer should not have recently collaborated with any of the authors
Reviewer nominees from the same institution as any of the authors are not permitted
You will also be asked to nominate peers who you do not wish to review your manuscript (opposed reviewers).
Please note that the Editors are not obliged to invite/ reject any recommended/opposed reviewers to assess your manuscript.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor / Board member will have no involvement in the decision-making process.
Diabetes and Vascular Disease Research is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for Journal Title can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.
4.2 Authorship
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
Drafted the article or revised it critically for important intellectual content,
Approved the version to be published,
Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
4.3 Acknowledgements
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
4.3.1 Third party submissions
Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:
• Disclose this type of editorial assistance – including the individual’s name, company and level of input
• Identify any entities that paid for this assistance
• Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.
Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.
4.3.2 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
……
更多详情：
https://journals.sagepub.com/author-instructions/DVR
